|
Status |
Public on Apr 14, 2015 |
Title |
LD-3 |
Sample type |
RNA |
|
|
Source name |
serum form LD SCLC patient
|
Organism |
Homo sapiens |
Characteristics |
gender: male age: 56y subject status: small cell lung cancer (SCLC) patient Stage: limited-stage tissue: patient's serum
|
Treatment protocol |
All serum was collected before any treatment
|
Growth protocol |
Patients' blood were collected and seperated in 4hours.
|
Extracted molecule |
total RNA |
Extraction protocol |
Total RNA extracted using Trizol following manufacturer's instructions
|
Label |
Cy3
|
Label protocol |
200ng of total RNA were used to fellow expriment follow miRNA Complete Labeling and Hyb Kit (Agilent) protocol.
|
|
|
Hybridization protocol |
Follow miRNA Complete Labeling and Hyb Kit (Agilent) protocol.
|
Scan protocol |
Scanned on an Agilent G2565CA scanner.
|
Description |
miRNAs expression before treatment 050
|
Data processing |
Agilent Feature Extraction(v10.7)was used for background subtraction and Agilent GeneSpring was used to normalization.
|
|
|
Submission date |
Apr 13, 2015 |
Last update date |
Apr 14, 2015 |
Contact name |
Rui Zhou |
E-mail(s) |
[email protected]
|
Phone |
+8613971523840
|
Organization name |
Wuhan Union Hospital
|
Department |
Cancer Center
|
Street address |
湖北省武汉市江汉区唐家墩156号
|
City |
Wuhan |
State/province |
Hubei |
ZIP/Postal code |
430023 |
Country |
China |
|
|
Platform ID |
GPL16543 |
Series (1) |
GSE67804 |
miRNAs related to metastasis of Small Cell Lung Cancer |
|